Effectiveness of deferred therapy with ganciclovir in renal allograft recipients with cytomegalovirus disease (Q43455791)

23 November 2017

Effectiveness of deferred therapy with ganciclovir in renal allograft recipients with cytomegalovirus disease (English)

1 reference

23 November 2017

Waiser J

1

1 reference

23 November 2017

Budde K

2

1 reference

23 November 2017

Schreiber M

3

1 reference

23 November 2017

Korn K

4

1 reference

23 November 2017

Stenglein S

5

1 reference

23 November 2017

Drenckhahn JT

6

1 reference

23 November 2017

Böhler T

7

1 reference

23 November 2017

Hauser I

8

1 reference

23 November 2017

Neumayer HH

9

1 reference

23 November 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

Transplantation Proceedings

23 November 2017

1 reference

23 November 2017

30

1 reference

23 November 2017

5

1 reference

23 November 2017

2083-2085

1 reference

Cytomegalovirus directly enhances MHC class I and intercellular adhesion molecule-1 expression on cultured proximal tubular epithelial cells

23 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900547-8

7 January 2021

CMV infection, class II antigen expression, and human kidney allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900547-8

7 January 2021

Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900547-8

7 January 2021

The association of the induction of vascular cell adhesion molecule-1 with cytomegalovirus antigenemia in human heart allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900547-8

7 January 2021

Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900547-8

7 January 2021

Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900547-8

7 January 2021

Incidence and morbidity of cytomegalovirus disease associated with a seronegative recipient receiving seropositive donor-specific transfusion and living-related donor transplantation. A multicenter evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900547-8

7 January 2021

Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900547-8

7 January 2021

Cytomegalovirus Infection in Patients with Renal Transplants: Potentiation by Antithymocyte Globulin and an Incompatible Graft

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900547-8

7 January 2021

The polymerase chain reaction, a sensitive and rapid technique for detecting cytomegalovirus infection after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900547-8

7 January 2021

Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900547-8

7 January 2021

Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900547-8

7 January 2021

Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900547-8

7 January 2021

10.1016/S0041-1345(98)00547-8

Identifiers

DOI

1 reference

23 November 2017

1 reference